Soma Pharmacy Blognews

Alnylam, Collaborators At MIT Publish New Pre-clinical Research On Lipidoid Formulations
For the systemic delivery of RNAi therapeutics

CVS Caremark to provide H1N1 flu vaccinations at select locations
CVS Caremark announced today that it will provide H1N1 flu vaccinations at select CVS/pharmacy locations in the States of Alabama, Illinois, Kansas, Missouri, Pennsylvania and New York as well at MinuteClinic locations in Massachusetts and Connecticut beginning Thursday, December 31.

FDA accepts NDA review for new anticonvulsant drug
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to [...]

Biodel submits NDA to FDA for clearance to market VIAject
Biodel, Inc. announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes.

J&JPRD receives FDA Complete Response Letter for ceftobiprole
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Application (NDA) was originally submitted to the FDA in May 2007 for the treatment of complicated skin and [...]

Meda expands collaboration with Etypharm for Axorid
Meda expands the collaboration with the French development company Etypharm for the patented product Axorid. New territories, such as East Europe with Russia and Turkey, are now included in the collaboration. Previously, Meda held commercialization rights in Central and West Europe.

Liraglutide FDA feedback expected within weeks, says Novo Nordisk
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.

Competitive intelligence on Egypt’s pharmaceuticals and healthcare industry
Research and Markets has announced the addition of the “Egypt Pharmaceuticals and Healthcare Report Q1 2010″ report to their offering.

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC
New research findings published this week on a standardized Ginkgo biloba extract are very limited and the public should focus on the well-documented cognitive and cardiovascular benefits of ginkgo, said the American Botanical Council (ABC), an independent nonprofit research and education organization.

CRN stands by Ginkgo biloba’s effectiveness in improving cognitive function
“It is important to put this study into context and to remember that there is a large body of previously published evidence, which suggests that Ginkgo biloba may help improve cognitive impairment in older adults. There are also additional ongoing clinical trials, the results of which [...]